RMC Pharmaceutical Solutions Revenue and Competitors

Boulder, CO USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • RMC Pharmaceutical Solutions's estimated annual revenue is currently $3.3M per year.(i)
  • RMC Pharmaceutical Solutions's estimated revenue per employee is $155,000

Employee Data

  • RMC Pharmaceutical Solutions has 21 Employees.(i)
  • RMC Pharmaceutical Solutions grew their employee count by -22% last year.

RMC Pharmaceutical Solutions's People

NameTitleEmail/Phone
1
President/CEO Reveal Email/Phone
2
Accountant/Office managerReveal Email/Phone
3
Quality Systems ManagerReveal Email/Phone
4
Business & Finance ManagerReveal Email/Phone
5
Sr. ConsultantReveal Email/Phone
6
Senior ConsultantReveal Email/Phone
7
Senior ConsultantReveal Email/Phone
8
Senior ConsultantReveal Email/Phone
9
founding memberReveal Email/Phone
10
Senior ConsultantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.7M110%N/AN/A
#2
$2.8M1813%N/AN/A
#3
$70.2M453-1%N/AN/A
#4
$1.6M10-66%N/AN/A
#5
$3.7M24-8%N/AN/A
#6
$2.9M3728%N/AN/A
#7
$3.1M2025%N/AN/A
#8
$2.5M16-20%N/AN/A
#9
$9.1M590%N/AN/A
#10
$4.2M27-7%N/AN/A
Add Company

What Is RMC Pharmaceutical Solutions?

RMC Pharmaceutical Solutions Incorporated (RMC) is an expert technical services organization with a focus on solving CMC (Chemistry, Manufacturing and Control) issues in the bio/pharmaceutical industry. We support areas such as process, analytical and formulation development; quality control and quality assurance; GLP/GMP manufacturing of API and drug product; and packaging/distribution. Our team has the experience and talent to handle any product development project for a new therapeutic, diagnostic or device.

keywords:N/A

N/A

Total Funding

21

Number of Employees

$3.3M

Revenue (est)

-22%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.6M21-45%N/A
#2
N/A21-16%N/A
#3
$3.8M225%N/A
#4
$2.2M2210%N/A
#5
$5.4M22-4%N/A